Jennifer M Streit
About
Jennifer M Streit is a scholar working on Molecular Medicine, Infectious Diseases and Clinical Biochemistry.
According to data from OpenAlex, Jennifer M Streit has authored 73 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 42 papers in Molecular Medicine, 38 papers in Infectious Diseases and 36 papers in Clinical Biochemistry. Recurrent topics in Jennifer M Streit's work include Antibiotic Resistance in Bacteria (42 papers), Antimicrobial Resistance in Staphylococcus (37 papers) and Bacterial Identification and Susceptibility Testing (36 papers). Jennifer M Streit is often cited by papers focused on Antibiotic Resistance in Bacteria (42 papers), Antimicrobial Resistance in Staphylococcus (37 papers) and Bacterial Identification and Susceptibility Testing (36 papers). Jennifer M Streit collaborates with scholars based in United States, Brazil and Switzerland. Jennifer M Streit's co-authors include Hélio S. Sader, Ronald N. Jones, Thomas R. Fritsche, Robert K. Flamm, Rodrigo E. Mendes, Mariana Castanheira, Patricia A. Hogan, Michael A. Pfaller, Dee Shortridge and Cecília G Carvalhaes and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and Clinical Microbiology and Infection.
In The Last Decade
Jennifer M Streit
71 papers receiving 1.8k citations
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jennifer M Streit United States | 25 | 1.0k | 782 | 674 | 509 | 419 | 73 | 1.8k | ||
| Deborah C. Draghi United States | 22 | 783 0.8× | 742 0.9× | 546 0.8× | 447 0.9× | 513 1.2× | 33 | 1.9k | ||
| Ellie Hershberger United States | 24 | 1.1k 1.0× | 966 1.2× | 651 1.0× | 915 1.8× | 764 1.8× | 39 | 2.3k | ||
| Barbara Fiori Italy | 25 | 1.2k 1.1× | 796 1.0× | 733 1.1× | 263 0.5× | 1.2k 2.9× | 64 | 2.6k | ||
| Simona Barnini Italy | 25 | 401 0.4× | 1.1k 1.4× | 492 0.7× | 509 1.0× | 641 1.5× | 59 | 1.9k | ||
| Dee Shortridge United States | 29 | 528 0.5× | 1.3k 1.7× | 368 0.5× | 800 1.6× | 768 1.8× | 85 | 2.6k | ||
| D. Milatović Germany | 23 | 1.1k 1.1× | 721 0.9× | 588 0.9× | 481 0.9× | 722 1.7× | 59 | 2.2k | ||
| Ronald N. Jones United States | 18 | 550 0.5× | 675 0.9× | 484 0.7× | 415 0.8× | 454 1.1× | 45 | 1.5k | ||
| Yuxing Ni China | 30 | 767 0.7× | 1.2k 1.5× | 385 0.6× | 375 0.7× | 908 2.2× | 75 | 2.3k | ||
| Chris M. Pillar United States | 23 | 623 0.6× | 573 0.7× | 291 0.4× | 484 1.0× | 287 0.7× | 45 | 1.4k | ||
| Michael J. Dowzicky United States | 33 | 827 0.8× | 1.9k 2.5× | 747 1.1× | 887 1.7× | 609 1.5× | 80 | 2.8k |
Countries citing papers authored by Jennifer M Streit
Since
Specialization
Citations
This map shows the geographic impact of Jennifer M Streit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer M Streit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer M Streit more than expected).
Fields of papers citing papers by Jennifer M Streit
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jennifer M Streit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer M Streit. The network helps show where Jennifer M Streit may publish in the future.
Co-authorship network of co-authors of Jennifer M Streit
This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer M Streit. A scholar is included among the top collaborators of Jennifer M Streit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer M Streit. Jennifer M Streit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Carvalhaes, Cecília G, Hélio S. Sader, Jennifer M Streit, & Rodrigo E. Mendes. (2022). Five-year analysis of the in vitro activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programme. JAC-Antimicrobial Resistance. 4(5). dlac088–dlac088.
2.
Shortridge, Dee, Jennifer M Streit, Michael D. Huband, & Mariana Castanheira. (2022). 2176. In Vitro Evaluation of Delafloxacin Activity Against Contemporary US Isolates from Cystic Fibrosis Patients Hospitalized with Pneumonia: Results from the SENTRY Antimicrobial Surveillance Program (2019-2021). Open Forum Infectious Diseases. 9(Supplement_2).
3.
Pfaller, Michael A., Rodrigo E. Mendes, Jennifer M Streit, & Cecília G Carvalhaes. (2022). Tedizolid in vitro activity against Gram-positive clinical isolates causing bone and joint infections in hospitals in the USA, Europe, Latin America, and the Asia-Pacific region (2015-2019). Diagnostic Microbiology and Infectious Disease. 104(4). 115804–115804.
4.
Sader, Hélio S., Mariana Castanheira, Jennifer M Streit, Cecília G Carvalhaes, & Rodrigo E. Mendes. (2020). Frequency and antimicrobial susceptibility of bacteria causing bloodstream infections in pediatric patients from United States (US) medical centers (2014–2018): therapeutic options for multidrug-resistant bacteria. Diagnostic Microbiology and Infectious Disease. 98(2). 115108–115108.
5.
Deshpande, Lalitagauri M., et al.. (2020). 1590. Activity of Meropenem-Vaborbactam and Single-Agent Comparators against Enterobacterales Isolates Including KPC-Producing Isolates, from European Patients Hospitalized with Pneumonia Including Ventilator-Associated Pneumonia (2014-2019). Open Forum Infectious Diseases. 7(Supplement_1). S792–S792.
6.
Mendes, Rodrigo E., Michael D. Huband, Jennifer M Streit, Mariana Castanheira, & Robert K. Flamm. (2020). Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms. Diagnostic Microbiology and Infectious Disease. 97(3). 115054–115054.
7.
Sader, Hélio S., Cecília G Carvalhaes, Jennifer M Streit, S J Ryan Arends, & Rodrigo E. Mendes. (2020). Antimicrobial activity of dalbavancin against clinical isolates of coagulase-negative staphylococci from the USA and Europe stratified by species. Journal of Global Antimicrobial Resistance. 24. 48–52.
8.
Sader, Hélio S., Cecília G Carvalhaes, Jennifer M Streit, Timothy B Doyle, & Mariana Castanheira. (2020). Antimicrobial Activity of Ceftazidime-Avibactam, Ceftolozane-Tazobactam and Comparators Tested Against Pseudomonas aeruginosa and Klebsiella pneumoniae Isolates from United States Medical Centers in 2016–2018. Microbial Drug Resistance. 27(3). 342–349.
9.
Sader, Hélio S., Mariana Castanheira, Jennifer M Streit, & Robert K. Flamm. (2019). Frequency of occurrence and antimicrobial susceptibility of bacteria isolated from patients hospitalized with bloodstream infections in United States medical centers (2015–2017). Diagnostic Microbiology and Infectious Disease. 95(3). 114850–114850.
10.
Sader, Hélio S., Cecília G Carvalhaes, Jennifer M Streit, Mariana Castanheira, & Robert K. Flamm. (2019). Antimicrobial activity of cefoperazone-sulbactam tested against Gram-Negative organisms from Europe, Asia-Pacific, and Latin America. International Journal of Infectious Diseases. 91. 32–37.
11.
Shortridge, Dee, S J Ryan Arends, Leonard R Duncan, Jennifer M Streit, & Robert K. Flamm. (2019). 1589. Ceftolozane–Tazobactam Activity Against Difficult-to-Treat Resistance in Pseudomonas aeruginosa from Bloodstream Infections in US Hospitals. Open Forum Infectious Diseases. 6(Supplement_2). S580–S580.
12.
Sader, Hélio S., Robert K. Flamm, Jennifer M Streit, Cecília G Carvalhaes, & Rodrigo E. Mendes. (2018). Antimicrobial activity of ceftaroline and comparator agents tested against organisms isolated from patients with community-acquired bacterial pneumonia in Europe, Asia, and Latin America. International Journal of Infectious Diseases. 77. 82–86.
13.
Mendes, Rodrigo E., Lalitagauri M. Deshpande, Jennifer M Streit, et al.. (2018). ZAAPS programme results for 2016: an activity and spectrum analysis of linezolid using clinical isolates from medical centres in 42 countries. Journal of Antimicrobial Chemotherapy. 73(7). 1880–1887.
14.
Pfaller, Michael A., Rodrigo E. Mendes, Jennifer M Streit, Patricia A. Hogan, & Robert K. Flamm. (2017). Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015). Antimicrobial Agents and Chemotherapy. 61(7).
15.
Paukner, Susanne, Hélio S. Sader, Jennifer M Streit, Robert K. Flamm, & Steven P Gelone. (2017). In Vitro Activity of Lefamulin Against a Global Collection of Bacterial Pathogens Commonly Causing Community-Acquired Bacterial Pneumonia (CABP, SENTRY 2015). Open Forum Infectious Diseases. 4(suppl_1). S373–S373.
16.
Sader, Hélio S., David J. Farrell, Robert K. Flamm, et al.. (2016). Antimicrobial activity of ceftaroline and comparator agents when tested against numerous species of coagulase-negative Staphylococcus causing infection in US hospitals. Diagnostic Microbiology and Infectious Disease. 85(1). 80–84.
17.
Streit, Jennifer M, Hélio S. Sader, Thomas R. Fritsche, & Ronald N. Jones. (2005). Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens. Diagnostic Microbiology and Infectious Disease. 53(4). 307–310.
18.
Streit, Jennifer M, Judith N. Steenbergen, Grace M. Thorne, Jeffrey Alder, & Ronald N. Jones. (2005). Daptomycin tested against 915 bloodstream isolates of viridans group streptococci (eight species) and Streptococcus bovis. Journal of Antimicrobial Chemotherapy. 55(4). 574–578.
19.
Sader, Hélio S., Jennifer M Streit, Thomas R. Fritsche, & Ronald N. Jones. (2004). Antimicrobial activity of daptomycin against multidrug-resistant gram-positive strains collected worldwide. Diagnostic Microbiology and Infectious Disease. 50(3). 201–204.
20.
Streit, Jennifer M, Thomas R. Fritsche, Hélio S. Sader, & Ronald N. Jones. (2003). Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates. Diagnostic Microbiology and Infectious Disease. 48(2). 137–143.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Deborah C. Draghi Breakdown of academic impact, for papers by Ellie Hershberger Breakdown of academic impact, for papers by Barbara Fiori Breakdown of academic impact, for papers by Simona Barnini Breakdown of academic impact, for papers by Dee Shortridge Breakdown of academic impact, for papers by D. Milatović Breakdown of academic impact, for papers by Ronald N. Jones Breakdown of academic impact, for papers by Yuxing Ni Breakdown of academic impact, for papers by Chris M. Pillar Breakdown of academic impact, for papers by Michael J. Dowzicky